首页> 外国专利> IRILIS BIOPREPARATION BASED ON BACILLUS-STRAIN BACTERIA, BACILLUS SUBTILIS AND BACILLUS LICHENIFORMIS CONTAINED THEREIN

IRILIS BIOPREPARATION BASED ON BACILLUS-STRAIN BACTERIA, BACILLUS SUBTILIS AND BACILLUS LICHENIFORMIS CONTAINED THEREIN

机译:其中包含杆菌菌株,杆菌芽孢杆菌和地衣芽孢杆菌的伊利利斯生物分离

摘要

A bioengineering, in particular to develop novel probiotic preparations based on Bacillus-strain bacteria, which can be used for preventing and treating infectious diseases and disbiosis of a human being, farm animals and birds. The novel strains of B. subtilis 07 (VKPM No. B-8611) and B. licheniformis 09 (VKPM No. B-8610) exhibit a broad spectrum of antagonistic activity, high proteolytic and amylase activity and a distinct ability in terms of a lysozim production. Such strains do not compete with each other but enter into synergistic relations in the form of an increased antagonistic action of the biopreparation. The inventive biopreparation comprises the B. subtilis 07 VKPM No. B-8611 and B. licheniformis 09 VKPM No. B-8610 strains and a protective medium. Such biopreparation can also contain a solvent and/or filler and exhibits an increased antagonistic activity with respect to a wide range of pathogenic and opportunistic pathogenic microorganisms and a resistance to quite a number of antibiotics.
机译:生物工程,特别是开发基于芽孢杆菌属细菌的新型益生菌制剂,其可用于预防和治疗人类,农场动物和鸟类的传染病和生物多样性。枯草芽孢杆菌07(VKPM编号B-8611)和地衣芽孢杆菌09(VKPM编号B-8610)的新菌株表现出广谱的拮抗活性,高蛋白水解和淀粉酶活性,并具有独特的能力。来苏辛生产。这些菌株彼此不竞争,但是以生物制剂的拮抗作用增加的形式进入协同关系。本发明的生物制剂包含枯草芽孢杆菌07VKPM编号B-8611和地衣芽孢杆菌09VKPM编号B-8610菌株和保护介质。这种生物制剂还可以包含溶剂和/或填充剂,并且对于多种致病性和机会性致病性微生物表现出增强的拮抗活性,并且对相当多种抗生素具有抗性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号